Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Typhoid Conjugate Vaccine Introduction Program in Navi Mumbai, India

NCT03554213 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03554213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03554213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Typhoid Conjugate Vaccine Introduction Program in Navi Mumbai, India
Lead sponsor
Stanford University
Phase
Observational
Overall status
Completed
Start date
July 2, 2018
Completion date
March 31, 2021
Enrollment
17,292 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

enteric fever, salmonella typhi infection, typhoid fever